Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Critical earnings dates you can't miss
See Calendar
Close

Cpr Invest - Global Disruptive Opportunities Class A H1 Eur Acc (0P0001FERF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
171.990 +2.160    +1.27%
17/07 - Closed. Currency in EUR
Type:  Fund
Market:  Luxembourg
ISIN:  LU1903290036 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 3.28B
CPR Invest - Global Disruptive Opportunities Class 171.990 +2.160 +1.27%

0P0001FERF Holdings

 
Comprehensive information about top holdings and Key Holding Information for the CPR Invest - Global Disruptive Opportunities Class (0P0001FERF) fund. Our CPR Invest - Global Disruptive Opportunities Class portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 1.180 25.680 24.500
Shares 98.790 98.800 0.010
Bonds 0.020 0.020 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 28.408 16.197
Price to Book 5.683 2.698
Price to Sales 5.074 2.104
Price to Cash Flow 18.249 10.284
Dividend Yield 0.858 2.811
5 Years Earnings Growth 10.001 12.055

Sector Allocation

Name  Net % Category Average
Technology 47.290 19.985
Healthcare 16.010 12.335
Industrials 12.660 14.182
Consumer Cyclical 10.230 12.324
Communication Services 5.480 9.350
Financial Services 3.960 20.340
Real Estate 2.440 4.556
Utilities 1.930 5.682

Region Allocation

  • North America
  • Latin America
  • Europe Developed
  • Asia
  • Africa & Middle East
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 371

Number of short holdings: 276

Name ISIN Weight % Last Change %
  Microsoft US5949181045 4.76 510.05 -0.32%
  NVIDIA US67066G1040 3.27 172.41 -0.34%
  Alphabet A US02079K3059 3.27 185.06 +0.81%
  Taiwan Semiconductor US8740391003 2.89 240.40 -2.12%
  Boston Scientific US1011371077 2.88 103.64 -0.97%
  Amazon.com US0231351067 2.84 226.13 +1.01%
  Hitachi JP3788600009 2.71 4,343.0 +2.53%
  Adyen NL0012969182 2.49 1,556.20 +0.30%
  Johnson Controls IE00BY7QL619 2.43 108.96 +0.01%
  Intuitive Surgical US46120E6023 2.28 518.62 +0.48%

Top Equity Funds by CPR Asset Management

  Name Rating Total Assets YTD% 3Y% 10Y%
  LU1530899142 3.28B -8.93 9.84 -
  LU2035461495 3.28B -8.70 10.18 -
  LU1530900684 3.28B -8.52 10.92 -
  LU1902443420 1.83B -2.91 10.42 -
  LU1902444402 1.83B -3.39 9.34 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0001FERF Comments

Write your thoughts about Cpr Invest - Global Disruptive Opportunities Class A H1 Eur Acc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email